Assignee
NOVO NORDISK HEALTHCARE AG
CH·40 granted patents·143 pending applications·558 citations·filing 2001–2025
Top patents by PatentIndex Score
183 records- 0197US11980611B2Treating sickle cell disease with a pyruvate kinase R activating compoundNOVO NORDISK HEALTHCARE AG·Filed 2022·Granted May 14, 2024·3 cites·4 claims
- 0297US11844787B2Activating pyruvate kinase RNOVO NORDISK HEALTHCARE AG·Filed 2021·Granted Dec 19, 2023·5 cites·4 claims
- 0395US7524813B2Selectively conjugated peptides and methods of making the sameNOVO NORDISK HEALTHCARE AG·Filed 2006·Granted Apr 28, 2009·72 cites·3 claims
- 0494US7235638B2Coagulation factor VII derivativesNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Jun 26, 2007·56 cites·9 claims
- 0594US7026524B2Human coagulation factor VII variantsNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Apr 11, 2006·59 cites·26 claims
- 0692US8779109B2Growth hormones with prolonged in-vivo efficacyNOVO NORDISK HEALTHCARE AG·Filed 2013·Granted Jul 15, 2014·17 cites·11 claims
- 0792US7416861B2Human coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2005·Granted Aug 26, 2008·14 cites·7 claims
- 0891US7521210B2Method for large-scale production of polypeptide in eukaryote cells and a culture vessel suitable thereforNOVO NORDISK HEALTHCARE AG·Filed 2006·Granted Apr 21, 2009·67 cites·15 claims
- 0991US7419949B2Single-dose administration of factor VIIaNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Sep 2, 2008·26 cites·9 claims
- 1091US6911323B2Human coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2003·Granted Jun 28, 2005·31 cites·39 claims
- 1190US9370583B2Coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2015·Granted Jun 21, 2016·4 cites·10 claims
- 1289US7432352B2Hybrid molecules having Factor VII/VIIa activityNOVO NORDISK HEALTHCARE AG·Filed 2006·Granted Oct 7, 2008·16 cites·9 claims
- 1389US7176288B2Human coagulation factor VII variantsNOVO NORDISK HEALTHCARE AG·Filed 2001·Granted Feb 13, 2007·29 cites·10 claims
- 1489US6960657B2Human coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Nov 1, 2005·21 cites·22 claims
- 1588US12071440B2Pyrrolopyrrole compositions as pyruvate kinase (PKR) activatorsNOVO NORDISK HEALTHCARE AG·Filed 2023·Granted Aug 27, 2024·0 cites·4 claims
- 1688US6905683B2Human coagulation factor VII variantsNOVO NORDISK HEALTHCARE AG·Filed 2001·Granted Jun 14, 2005·15 cites·19 claims
- 1787US7125846B2Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Oct 24, 2006·37 cites·19 claims
- 1885US7732405B2Liquid, aqueous pharmaceutical compositions of factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2006·Granted Jun 8, 2010·8 cites·37 claims
- 1984US12128035B2Activating pyruvate kinase RNOVO NORDISK HEALTHCARE AG·Filed 2022·Granted Oct 29, 2024·1 cites·21 claims
- 2084US8026214B2Liquid, aqueous pharmaceutical compositions of factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2009·Granted Sep 27, 2011·7 cites·9 claims
- 2184US7897734B2Method for the production of proteinsNOVO NORDISK HEALTHCARE AG·Filed 2005·Granted Mar 1, 2011·5 cites·12 claims
- 2284US7786070B2Subcutaneous administration of coagulation factor VIINOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Aug 31, 2010·16 cites·8 claims
- 2384US7078479B2Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Jul 18, 2006·26 cites·17 claims
- 2484US7052868B2Human coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted May 30, 2006·9 cites·45 claims
- 2579US2025283091A1Methods and compositions for inhibiting expression of ldhaNOVO NORDISK HEALTHCARE AG·Filed 2025·Application pending·0 cites
- 2678US7858338B2Processing enzymes fused to basic protein tagsNOVO NORDISK HEALTHCARE AG·Filed 2007·Granted Dec 28, 2010·2 cites·19 claims
- 2777US2024182901A1Methods and compositions for inhibiting expression of ldhaNOVO NORDISK HEALTHCARE AG·Filed 2022·Application pending·0 cites
- 2876US7291587B2Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Nov 6, 2007·8 cites·68 claims
- 2975US12053458B2Treating sickle cell disease with a pyruvate kinase R activating compoundNOVO NORDISK HEALTHCARE AG·Filed 2019·Granted Aug 6, 2024·0 cites·12 claims
- 3075US2020102568A1Growth Hormones with Prolonged In-Vivo EfficacyNOVO NORDISK HEALTHCARE AG·Filed 2019·Application pending·0 cites
- 3174US8921530B2Method for the production of proteinsNOVO NORDISK HEALTHCARE AG·Filed 2013·Granted Dec 30, 2014·1 cites·13 claims
- 3274US2022054604A1Stabilised Compositions of Factor VII PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2021·Application pending·0 cites
- 3372US2020254072A1Stabilised Solid Compositions of Factor VII PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2020·Application pending·0 cites
- 3472US2022073895A1Human coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2021·Application pending·0 cites
- 3571US12122778B2Activating pyruvate kinase RNOVO NORDISK HEALTHCARE AG·Filed 2019·Granted Oct 22, 2024·0 cites·19 claims
- 3670US2019328851A1Stabilised Solid Compositions of Factor VII PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2019·Application pending·0 cites
- 3770US2019307862A1SINGLE-DOSE ADMINISTRATION OF FACTOR VIIaNOVO NORDISK HEALTHCARE AG·Filed 2019·Application pending·0 cites
- 3870US2022064605A1Virus Filtration of Liquid Factor VII CompositionsNOVO NORDISK HEALTHCARE AG·Filed 2021·Application pending·0 cites
- 3969US9480623B2Pre-assembled fluid transfer arrangementNOVO NORDISK HEALTHCARE AG·Filed 2012·Granted Nov 1, 2016·3 cites·25 claims
- 4068US2019091303A1SINGLE-DOSE ADMINISTRATION OF FACTOR VIIaNOVO NORDISK HEALTHCARE AG·Filed 2018·Application pending·0 cites
- 4168US2019111118A1Stabilised Solid Compositions of Factor VII PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2018·Application pending·0 cites
- 4267US2020046812A1Stabilised Compositions of Factor VII PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2019·Application pending·0 cites
- 4367US2006276398A1Combined use of factor VII polypeptides and factor VIII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 4466US2006211621A1Combined use of factor VII polypeptides and factor IX polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 4566US2019000934A1SINGLE-DOSE ADMINISTRATION OF FACTOR VIIaNOVO NORDISK HEALTHCARE AG·Filed 2018·Application pending·0 cites
- 4665US2018085439A1Stabilised Solid Compositions of Factor VII PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2017·Application pending·0 cites
- 4765US2020306382A1Growth Hormones with Prolonged In-Vivo EfficacyNOVO NORDISK HEALTHCARE AG·Filed 2020·Application pending·0 cites
- 4865US2014178356A1Stabilised Solid Compositions of Factor VII PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2014·Application pending·0 cites
- 4964US2008318276A1Human Coagulation Factor VII VariantsNOVO NORDISK HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 5064US2010028939A1Use of Galactose Oxidase for Selective Chemical Conjugation of Protractor Molecules to Proteins of Therapeutic InterestNOVO NORDISK HEALTHCARE AG·Filed 2008·Application pending·0 cites
Showing the top 50 of 183 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when NOVO NORDISK HEALTHCARE AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →